These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7508871)
1. Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine. Yin D; Kondo S; Takeuchi J; Morimura T FEBS Lett; 1994 Feb; 339(1-2):73-5. PubMed ID: 7508871 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in rat somatotrophin-secreting pituitary adenoma cells by bromocriptine. Yin D; Kondo S; Takeuchi J; Morimura T Oncol Res; 1993; 5(9):383-7. PubMed ID: 8038459 [TBL] [Abstract][Full Text] [Related]
3. Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism. Adams EF; Ashby MJ; Brown SM; White MC; Mashiter K Clin Endocrinol (Oxf); 1981 Nov; 15(5):479-84. PubMed ID: 6276051 [TBL] [Abstract][Full Text] [Related]
4. The Effects of Smad3 on Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Development, Cell Proliferation, Apoptosis, and Hormone Secretion. Zhou YZ; Li CZ; Gao H; Zhang YZ World Neurosurg; 2018 Jun; 114():e329-e337. PubMed ID: 29524699 [TBL] [Abstract][Full Text] [Related]
5. Bcl-2 gene prevents apoptosis in murine acth-secreting adenoma cells induced by bromocriptine. Yin D; Kondo S; Takeuchi J; Morimura T; Vaux D Int J Oncol; 1994 Jan; 4(1):187-91. PubMed ID: 21566911 [TBL] [Abstract][Full Text] [Related]
7. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine. Li Q; Su Z; Liu J; Cai L; Lu J; Lin S; Xiong Z; Li W; Zheng W; Wu J; Zhuge Q; Wu Z Mol Cell Endocrinol; 2014 Jan; 382(1):377-384. PubMed ID: 24184771 [TBL] [Abstract][Full Text] [Related]
9. Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines. Wang X; Du Q; Mao Z; Fan X; Hu B; Wang Z; Chen Z; Jiang X; Wang Z; Lei N; Wang H; Zhu Y Oncotarget; 2017 Jul; 8(28):45874-45887. PubMed ID: 28501857 [TBL] [Abstract][Full Text] [Related]
10. Hypersecretion of gonadotropins by a pituitary adenoma: pituitary dynamic studies and treatment with bromocriptine in one patient. Comtois R; Bouchard J; Robert F Fertil Steril; 1989 Oct; 52(4):569-73. PubMed ID: 2806596 [TBL] [Abstract][Full Text] [Related]
11. Effects of bromocriptine on cell cycle distribution and cell morphology in cultured rat pituitary adenoma cells. Johansen PW; Clausen OP; Haug E; Fossum S; Gautvik KM Acta Endocrinol (Copenh); 1985 Nov; 110(3):319-28. PubMed ID: 4072574 [TBL] [Abstract][Full Text] [Related]
12. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675 [TBL] [Abstract][Full Text] [Related]
13. The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro. Gruszka A; Kunert-Radek J; Radek A; Pisarek H; Taylor J; Dong JZ; Culler MD; Pawlikowski M Life Sci; 2006 Jan; 78(7):689-93. PubMed ID: 16115652 [TBL] [Abstract][Full Text] [Related]
14. Effect of bromocriptine and SMS 201-995 on growth of human somatotrophic and non-functioning pituitary adenoma cells in vitro. Renner U; Mojto J; Lange M; Müller OA; von Werder K; Stalla GK Eur J Endocrinol; 1994 Jan; 130(1):80-91. PubMed ID: 8124483 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary. Dall'Ara A; Lima L; Cocchi D; Di Salle E; Cancio E; Devesa J; Müller EE Eur J Pharmacol; 1988 Jun; 151(1):97-102. PubMed ID: 3416930 [TBL] [Abstract][Full Text] [Related]
16. Tumour ploidy in DNA histograms of pituitary adenomas. Lüdecke DK; Beck-Bornholdt HP; Saeger W; Schmidt W Acta Neurochir (Wien); 1985; 76(1-2):18-22. PubMed ID: 2988290 [TBL] [Abstract][Full Text] [Related]
17. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism. Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo. Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056 [TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas. Hofland LJ; de Herder WW; Waaijers M; Zuijderwijk J; Uitterlinden P; van Koetsveld PM; Lamberts SW J Clin Endocrinol Metab; 1999 Sep; 84(9):3336-43. PubMed ID: 10487708 [TBL] [Abstract][Full Text] [Related]
20. Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells. Miller M; Chen S; Woodliff J; Kansra S Endocrinology; 2008 Aug; 149(8):4158-67. PubMed ID: 18450960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]